MMED (Minimed Group) ROC (Joel Greenblatt) %: -36.12% (As of Jan. 2026)


MMED Minimed Group Inc MMED
15 GF Score
Price $14.28
! 1 Warning Sign
View Full Analysis

What is Minimed Group ROC (Joel Greenblatt) %?

Minimed Group MMED +0.14% 15 ROC (Joel Greenblatt) % is -36.12% as of Jan. 2026. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 841 Medical Devices & Instruments companies, Minimed Group ranks worse than 62.43% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Minimed Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was -36.12%.

The historical rank and industry rank for Minimed Group's ROC (Joel Greenblatt) % or its related term are showing as below:

MMED' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -13.12   Med: -5.47   Max: -3.79
Current: -13.12

During the past 3 years, Minimed Group's highest ROC (Joel Greenblatt) % was -3.79%. The lowest was -13.12%. And the median was -5.47%.

MMED's ROC (Joel Greenblatt) % is ranked worse than
62.43% of 841 companies
in the Medical Devices & Instruments industry
Industry Median: 4.13 vs MMED: -13.12

Minimed Group's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Minimed Group  (NAS:MMED) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Minimed Group ROC (Joel Greenblatt) % Related Terms


Minimed Group ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Minimed Group's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group ROC (Joel Greenblatt) % Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25
ROC (Joel Greenblatt) %
0.00 -7.14 -3.79

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26
ROC (Joel Greenblatt) % 0.00 9.10 -16.26 0.00 -36.12

MMED vs ICUI, WRBY, MMSI: ROC (Joel Greenblatt) % Comparison

For the Medical Instruments & Supplies subindustry, Minimed Group's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Minimed Group ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Minimed Group's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Minimed Group's ROC (Joel Greenblatt) % falls into.


MMED
15GF Score
Minimed Group Inc MMED
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minimed Group ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Oct. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(166 + 362 + 13) - (257 + 0 + 93)
=191

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(653 + 407 + 38) - (489 + 13 + 183)
=413

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Minimed Group for the quarter that ended in Jan. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Jan. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2025  Q: Jan. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-372/( ( (755 + max(191, 0)) + (701 + max(413, 0)) )/ 2 )
=-372/( ( 946 + 1114 )/ 2 )
=-372/1030
=-36.12 %

Note: The EBIT data used here is four times the quarterly (Jan. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -36.12% mean?
Minimed Group (MMED) has a ROC (Joel Greenblatt) % of -36.12% as of Jan. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Minimed Group and its competitors. According to the industry distribution chart, Minimed Group ranks #525 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 62.4%.
Is Minimed Group's ROC (Joel Greenblatt) % too high?
Minimed Group's current ROC (Joel Greenblatt) % is -36.12%. Based on the distribution chart, Minimed Group ranks #525 out of 841 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's ROC (Joel Greenblatt) % compare to ICUI and WRBY?
According to the Medical Devices & Instruments industry distribution chart, Minimed Group ranks #525 out of 841 companies for ROC (Joel Greenblatt) %. This places Minimed Group in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 4.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.13, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Minimed Group and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Minimed Group's current ROC (Joel Greenblatt) % is -36.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current ROC (Joel Greenblatt) % of -36.12%. The current ROC (Joel Greenblatt) % is -36.12%. Minimed Group's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Minimed Group (MMED), the current ROC (Joel Greenblatt) % is -36.12% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges B8S:Germany
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score

Get the complete analysis for MMED

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.28
Price